| # | Drug | Count |
|---|---|---|
| 0 | ACITRETIN | 13 |
| 1 | BELIMUMAB | 13 |
| 2 | DIAZEPAM | 13 |
| 3 | DIAZEPAM ORAL | 13 |
| 4 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 13 |
| 5 | LORAZEPAM | 13 |
| 6 | METHYLPREDNISOLONE | 13 |
| 7 | PREDNISONE | 13 |
| 8 | TACROLIMUS | 13 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACITRETIN | 13 | 0.0026 |
| 1 | BELIMUMAB | 13 | 0.0004 |
| 2 | METHYLPREDNISOLONE SODIUM SUCCINATE | 12 | 0.0003 |
| 3 | ERGOCALCIFEROL | 5 | 0.0002 |
| 4 | DIAZEPAM ORAL | 13 | 0.0001 |
| 5 | DIAZEPAM | 13 | 0.0001 |
| 6 | TACROLIMUS OINTMENT 0.1% | 13 | 0.0001 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 13 | 0.0001 |
| 8 | METHYLPREDNISOLONE | 13 | 0.0001 |
| 9 | MYCOPHENOLATE MOFETIL | 12 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 13 |
| 1 | Benzodiazepine [EPC] | 13 |
| 2 | Corticosteroid [EPC] | 13 |
| 3 | Interleukin-17A Antagonist [EPC] | 13 |
| 4 | Retinoid [EPC] | 13 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 11 |
| 6 | Provitamin D2 Compound [EPC] | 7 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 2 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 13 | 0.0004 |
| 1 | Interleukin-17A Antagonist [EPC] | 13 | 0.0003 |
| 2 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 3 | Retinoid [EPC] | 13 | 0.0001 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 11 | 0.0000 |
| 6 | Benzodiazepine [EPC] | 13 | 0.0000 |
| 7 | Corticosteroid [EPC] | 13 | 0.0000 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 2 | 0.0000 |